12/14/2023
Antharis Therapeutics Announces Successful Close of Their Series A.
SAN DIEGO—Antharis Therapeutics Inc., a biopharmaceutical company developing a leading portfolio of oncology and neurology related immunotherapeutics, today announced the completion of their Series A funding.
